Cerus' INTERCEPT Blood System May Benefit from CMS' Decision
Centres for Medicare & Medicaid Services (CMS) has given permanent Healthcare Common Procedure Coding System (HCPCS) Level II codes for pathogen-reduced platelet and plasma components. Currently, Cerus’ (NASDAQ:CERS) INTERCEPT Blood System is the only FDA-approved system for pathogen reduction of platelet and plasma components, intended to reduce the risk of transfusion transmitted infections.
Centres for Medicare & Medicaid Services (CMS) has given permanent Healthcare Common Procedure Coding System (HCPCS) Level II codes for pathogen-reduced platelet and plasma components. Currently, Cerus’ (NASDAQ:CERS) INTERCEPT Blood System is the only FDA-approved system for pathogen reduction of platelet and plasma components, intended to reduce the risk of transfusion transmitted infections.
According to the press release:
“The proportion of platelets transfused by hospitals on an outpatient basis is significant today, and continues to grow. These new billing codes now allow hospitals to bill and secure reimbursement for INTERCEPT-treated platelet and plasma components in this setting,” commented William “Obi” Greenman, Cerus’ president and chief executive officer. “Notably, the rate for a pathogen-reduced platelet unit represents a premium of $153.56 over the rate of $488.29 for a unit of conventional apheresis platelets. We were pleased to see strong advocacy from industry groups such as AABB, and from many other industry and clinical leaders supporting reimbursement for these innovative products.”
The new codes and payment rates, outlined in the table below, were published by CMS on October 30 in the Hospital Outpatient Prospective Payment System (HOPPS) Final Rule for CY2016 and will become effective January 1, 2016. The interim payment rates for CY2016 were based on payment rates for existing products determined by CMS to be the best proxy to pathogen-reduced blood components. Hospital claims data will be used to calculate payment rates for these new products in CY2018, per usual CMS rate-setting methods.
MARKETS
COMMODITIES
Commodities | |||
---|---|---|---|
Gold | 1755.18 | -3.17 | |
Silver | 19.35 | -0.16 | |
Copper | 3.62 | -0.01 | |
Palladium | 2151.00 | +9.00 | |
Platinum | 911.00 | 0.00 | |
Oil | 89.90 | -0.60 | |
Heating Oil | 3.58 | -0.03 | |
Natural Gas | 9.12 | -0.07 |
DOWNLOAD FREE REPORTS
BROWSE COMPANIES BY SECTOR
- Agriculture Investing
- Phosphate Investing
- Potash Investing
- Base Metals Investing
- Copper Investing
- Iron Investing
- Lead Investing
- Nickel Investing
- Zinc Investing
- Battery Metals Investing
- Cobalt Investing
- Graphite Investing
- Lithium Investing
- Manganese Investing
- Vanadium Investing
- Critical Metals Investing
- Magnesium Investing
- Rare Earth Investing
- Scandium Investing
- Tantalum Investing
- Tellurium Investing
- Tungsten Investing
- Energy Investing
- Oil and Gas Investing
- Uranium Investing
- Gem Investing
- Diamond Investing
- Industrial Metals Investing
- Aluminum Investing
- Chromium Investing
- Coal Investing
- Molybdenum Investing
- Tin Investing
- Precious Metals Investing
- Gold Investing
- Palladium Investing
- Platinum Investing
- Silver Investing
- 3D Printing Investing
- Bitcoin Investing
- Blockchain Investing
- Cleantech Investing
- Cloud Investing
- Cryptocurrencies
- Data Investing
- Emerging Tech Investing
- Artificial Intelligence Investing
- Mobile Investing
- Robotics Investing
- Fintech Investing
- Gaming Investing
- Esports Investing
- Nanoscience Investing
- Graphene Investing
- Nanotech Investing
- Security Investing
Featured {{ post.primary_section_name }} Stocks
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.